Cancer BiologybioRxivPreprint
Mediator Kinase Inhibition Impedes Transcriptional Plasticity and Prevents Resistance to ERK/MAPK-Targeted Therapy in KRAS-Mutant Cancers
D. P. Nussbaum, C. A. Martz, A. M. Waters…·K. C. Wood
This study shows that Mediator kinase inhibition prevents resistance to ERK/MAPK inhibitors in KRAS-mutant cancers by blocking transcriptional plasticity.
DOI 10.1101/2022.09.17.508384